ASRS
CPRX

Arizona State Retirement System’s Catalyst Pharmaceutical CPRX Stock Holding History

Arizona State Retirement System’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$953K Sell
30,328
-1,609
-5% -$47.5K ﹤0.01% 1200
2026
Q1 		$791K Sell
31,937
-293
-0.9% -$6.98K ﹤0.01% 1227
2025
Q4 		$752K Sell
32,230
-2,024
-6% -$45.1K ﹤0.01% 1259
2025
Q3 		$675K Buy
34,254
+461
+1% +$9.48K ﹤0.01% 1344
2025
Q2 		$733K Buy
33,793
+3,029
+10% +$71.5K ﹤0.01% 1272
2025
Q1 		$746K Sell
30,764
-223
-0.7% -$5.02K ﹤0.01% 1209
2024
Q4 		$647K Buy
30,987
+377
+1% +$8.1K ﹤0.01% 1360
2024
Q3 		$609K Buy
30,610
+877
+3% +$16.3K ﹤0.01% 1387
2024
Q2 		$461K Buy
29,733
+654
+2% +$10.2K ﹤0.01% 1483
2024
Q1 		$464K Buy
29,079
+2,263
+8% +$34.1K ﹤0.01% 1493
2023
Q4 		$451K Sell
26,816
-1,993
-7% -$27.2K ﹤0.01% 1515
2023
Q3 		$337K Buy
28,809
+617
+2% +$8.25K ﹤0.01% 1603
2023
Q2 		$379K Sell
28,192
-455
-2% -$6.55K ﹤0.01% 1572
2023
Q1 		$475K Buy
28,647
+1,085
+4% +$17.9K ﹤0.01% 1427
2022
Q4 		$513K Buy
27,562
+1,028
+4% +$15.8K 0.01% 1364
2022
Q3 		$340K Sell
26,534
-14
-0.1% -$166 ﹤0.01% 1552
2022
Q2 		$186K Buy
26,548
+67
+0.3% +$491 ﹤0.01% 1959
2022
Q1 		$220K Buy
26,481
+151
+0.6% +$1.07K ﹤0.01% 1968
2021
Q4 		$178K Sell
26,330
-418
-2% -$2.75K ﹤0.01% 2117
2021
Q3 		$142K Sell
26,748
-63
-0.2% -$345 ﹤0.01% 2138
2021
Q2 		$154K Sell
26,811
-1,853
-6% -$9.56K ﹤0.01% 2172
2021
Q1 		$132K Buy
28,664
+138
+0.5% +$548 ﹤0.01% 2101
2020
Q4 		$95K Sell
28,526
-1,117
-4% -$3.75K ﹤0.01% 2074
2020
Q3 		$88K Buy
29,643
+7,470
+34% +$29.2K ﹤0.01% 1961
2020
Q2 		$102K Buy
22,173
+400
+2% +$1.8K ﹤0.01% 1786
2020
Q1 		$84K Buy
+21,773
New +$89.4K ﹤0.01% 1685

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arizona State Retirement System's CPRX Position: Q2 2026 in Review

Arizona State Retirement System reduced its Catalyst Pharmaceutical (CPRX) stake by 5% in Q2 2026, selling an estimated $47.5K and leaving 30,328 shares worth $953K. The position accounts for ﹤0.01% of the portfolio, ranked #1200.

Arizona State Retirement System first reported a position in CPRX in Q1 2020 and has held it in 26 quarters since. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Arizona State Retirement System held 30,328 shares of Catalyst Pharmaceutical worth $953K as of Q2 2026.
  • Arizona State Retirement System sold 1,609 Catalyst Pharmaceutical shares in Q2 2026, an estimated $47.5K.
  • Catalyst Pharmaceutical made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1200 holding.
  • Arizona State Retirement System first reported a position in Catalyst Pharmaceutical in Q1 2020 and has held it in 26 quarters since.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.